Naia Garners $5,300,000 Series A Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    Undisclosed San Francisco, CA 94103 USA
  • Company Description
    Naia Limited is a privately-held, international drug development company that employs an innovative global strategy to clinically advance drug candidates.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company intends to use the funds to continue to invest in its subsidiaries and their portfolio of therapeutic approaches, including a program focused on the treatment of SBS, an orphan indication.
  • M&A Terms
  • Venture Investor

Trending on Xconomy